Welcome OHDSI: Where’s our journey?
Journey through clinical characterization: Large-scale honest incidence
OHDSI network in action: The risk of angioedema associated with levetiracetam use
Comparative effectiveness of alendronate and raloxifene in reducing the risk of hip fracture
Improving palliative care using patient-level prediction
Precision medicine through patient-level prediction of adverse events
Towards an OHDSI-based Data-Sharing Infrastructure in Germany
Transforming Swedish health Care Data to the OMOP CDM
The feasibility of utilising the OHDSI network to generate large-scale evidence of the safety of biologics
Uncovering exposures responsible for birth season – Disease effects
Learning effective clinical treatment pathways for type-2 diabetes
Comparison of combination treatment in hypertension
Responses – COMING SOON!